3100 Phase Ib/II study of the pan-cyclin-dependent kinase (CDK) inhibitor roniciclib (BAY 1000394) in combination with chemotherapy as first-line therapy in subjects with extensive disease small cell lung cancer (ED-SCLC)

Saved in:
Bibliographic Details
Published inEuropean journal of cancer (1990) Vol. 51; p. S634
Main Authors Cho, B.C., Dy, G.K., Govindan, R., Kim, D.W., Pennell, N.A., Zalcman, G., Besse, B., Nogai, H., Rajagopalan, P., Ocker, M., Barlesi, F.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2015
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

More Information
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(16)31741-5